Cost effectiveness of rivaroxaban versus warfarin for the prevention of recurrent venous thromboembolism

Authors
Category Primary study
JournalBlood
Year 2012
This article has no abstract
Epistemonikos ID: d2901c47d9e2d4dfbf5f940c4cf19f4a48c083ed
First added on: Feb 05, 2025